The article discusses new tests for early detection of colorectal cancer, including RNA and DNA stool tests endorsed by the American Cancer Society (ACS). These tests show high sensitivity for detecting colorectal cancer and moderate sensitivity for identifying advanced precancerous lesions. However, the ACS notes that blood-based tests are not yet as reliable as existing methods for detecting precancerous conditions and early-stage cancer. In Spain, colorectal cancer screening is offered free of charge to individuals aged 50–74 through fecal occult blood tests. The updated guidelines emphasize informing patients about the advantages and disadvantages of available tests to aid decision-making.
Bias read (Center): The article provides factual information about medical advancements and guidelines without taking a stance or showing bias toward any political ideology, group, or policy. It focuses on health science and does not involve political controversy.





